Procure plasma and/or serum and other sample types from up to approximately 5,000 study subjects diagnosed positive for acute or chronic tropical or infectious diseases to evaluate the performance of new investigational devices or therapeutics.
- 5000 samples worldwide.
- EvergreenHealth providing 200 patient samples to evaluate antibodies in COVID-19 +ve patients.
Investigator
Diego Lopez de Castilla, MD, EvergreenHealth Infectious Disease Care
